Medical Daily

Dengue Outbreak In Jamaica: Know Symptoms, Steps To Prevent The Mosquito-Borne Illness

Jamaica has reported 565 cases of dengue. Although there are no confirmed dengue-related deaths in the country so far, six deaths are being investigated, health officials said.

Jamaica has reported 565 cases of dengue. Although there are no confirmed dengue-related deaths in the country so far, six deaths are being investigated, health officials said.

1 year 8 months ago

PAHO/WHO | Pan American Health Organization

Charting a resilient future: learning from COVID-19 for a safer tomorrow

Charting a resilient future: learning from COVID-19 for a safer tomorrow

Cristina Mitchell

25 Sep 2023

Charting a resilient future: learning from COVID-19 for a safer tomorrow

Cristina Mitchell

25 Sep 2023

1 year 8 months ago

Health News Today on Fox News

Dengue fever: What you need to know about the mosquito-borne illness sweeping Jamaica

Amid the outbreak of dengue fever currently sweeping Jamaica, health experts are warning about the dangers of the mosquito-borne illness.

Amid the outbreak of dengue fever currently sweeping Jamaica, health experts are warning about the dangers of the mosquito-borne illness.

Jamaica’s Ministry of Health & Wellness announced the outbreak on Saturday. As of Friday, the country had recorded 565 suspected, presumed and confirmed cases of dengue. 

A majority of the confirmed cases in the Caribbean nation have been in Kingston, Saint Andrew, Saint Catherine and Saint Thomas.

Six deaths are being investigated, but they have not been confirmed as dengue-related.

JAMAICA DECLARES DENGUE FEVER OUTBREAK WITH HUNDREDS OF CONFIRMED AND SUSPECTED CASES

Dengue fever is caused by one of four different types of dengue viruses, according to Mayo Clinic's website.

The fever is spread by mosquito bites and cannot be transmitted directly from person to person.

Women who become infected while pregnant may spread the dengue virus to the baby during childbirth, however.

In rare cases, dengue fever can be transmitted through organ transplant, blood transfusion or needle stick injury, per the CDC.

Dengue occurs primarily in tropical and subtropical regions. 

Although it is most concentrated in Latin America, Southeast Asia, the Western Pacific Islands and Africa, it has been emerging in parts of Europe and the southern U.S., according to Mayo Clinic.

Up to 400 million people worldwide get infected with dengue each year, according to the Centers for Disease Control and Prevention (CDC).

Approximately 100 million people experience illness from the infection, and 40,000 die from severe effects.

In mild cases, dengue fever causes flu-like symptoms (nausea, vomiting, body aches) and high fever, Mayo Clinic states.

About one in 20 people will develop a more severe form, called dengue hemorrhagic fever.

DENGUE FEVER CASES COULD REACH NEAR-RECORD HIGHS THIS YEAR: WHAT TO KNOW ABOUT THE TROPICAL INFECTIOUS DISEASE

Symptoms of severe dengue include belly pain, frequent vomiting, bleeding from the nose or gums, fatigue, irritability, restlessness, and blood in vomit or stool, per the CDC website.

In these cases, symptoms can include serious bleeding, a sudden drop in blood pressure and organ damage, which can sometimes be fatal.

"On occasions, the illness can progress to severe dengue, which can result in organ failure as well as bleeding (hemorrhage), and severe fluid depletion that can lead to shock and death," Dr. Jacquiline Bisasor McKenzie, chief medical officer of Jamaica’s Ministry of Health & Wellness, said in a statement on the Ministry of Health & Wellness website.

DENGUE VIRUS SPREADS ACROSS FLORIDA COUNTIES, HEALTH OFFICIALS SAY

"Persons experiencing fever, vomiting, severe abdominal pain, bleeding under the skin (petechial rash), feeling very weak or getting confused, are to seek immediate medical attention," she added.

Those who experience symptoms and have been in an area where dengue fever is common should see a health care provider right away, as severe effects can develop quickly, states the CDC.

Infected people should take acetaminophen for pain relief and fever control, drink hydrating fluids and rest, the agency said on its website.

A blood test is the only way to confirm dengue fever.

People who are infected with dengue fever develop long-term immunity to the type of virus that initially caused the infection, but they will still be susceptible to the other three types.

Those who have had dengue fever in the past are at a higher risk of contracting severe symptoms if they get it again, according to Mayo Clinic.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

In regions where dengue fever is prevalent, a vaccine called Dengvaxia is available to people between the ages of 9 and 45 who have previously been infected.

For people who have not previously had dengue fever, the vaccine has been shown to actually increase the risk of severe symptoms and hospitalization upon infection, Mayo Clinic states.

For those who cannot receive the vaccine, the best method of prevention is to protect against mosquito bites.

On its website, Mayo Clinic offers these recommendations for people who live in or travel to areas where dengue fever is common:

For more Health articles, visit www.foxnews.com/health

1 year 8 months ago

Health, infectious-disease, viruses, lifestyle, insects, Jamaica

PAHO/WHO | Pan American Health Organization

PAHO Director's Annual Report highlights lessons learned from the pandemic

PAHO Director's Annual Report highlights lessons learned from the pandemic

Cristina Mitchell

25 Sep 2023

PAHO Director's Annual Report highlights lessons learned from the pandemic

Cristina Mitchell

25 Sep 2023

1 year 8 months ago

PAHO/WHO | Pan American Health Organization

PAHO Director opens 60th Directing Council, reflects on progress towards five priority areas of work

PAHO Director opens 60th Directing Council, reflects on progress towards five priority areas of work

Cristina Mitchell

25 Sep 2023

PAHO Director opens 60th Directing Council, reflects on progress towards five priority areas of work

Cristina Mitchell

25 Sep 2023

1 year 8 months ago

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

Blue light from smartphones or tablets linked to early puberty

Exposure to blue light, like that from smartphones or tablets, may lead to early puberty in male rats, according to research presented at the 61st Annual European Society for Paediatric Endocrinology Meeting in The Hague.

This study is the first to investigate the association between blue light exposure and early puberty in male rats, and sheds light on how environmental factors, such as screen time, impact early puberty and testicular tissue, which could eventually lead to future prevention strategies for children.

Early puberty for most children does not have an obvious cause. Sometimes it is due to genetics, or there is a problem in the brain, such as an injury or tumour, or in the thyroid, adrenal or sex glands. In recent years, several studies have reported increases in early puberty onset for both girls and boys, particularly during the COVID-19 pandemic. One factor may be the increased use of blue light-emitting devices, but this is very difficult to assess in children.

In this study, researchers from the Ankara Bilkent City Hospital and Gazi University in Turkey examined 18 male rats aged 21-days-old, divided into three groups of six and exposed to either a normal light cycle, to six hours or 12 hours of blue light. The researchers found that the first signs of puberty occurred significantly earlier in male rats exposed to blue light. Additionally, the longer the rats were exposed to blue light, the earlier their puberty started, while they also showed suppressed sperm development and damaged testicular tissue.

A previous study from the same group has also shown an earlier onset of puberty in female rats due to blue light exposure. However, this association has never been studied in male rats before. “For the first time, we found a direct relationship between blue light exposure and early puberty in male rats,” said lead researcher Dr Aylin Kılınç Uğurlu from Ankara Bikent City Hospital. “Our findings align with our previous work on female rats, which also showed similar effects, thereby providing a more comprehensive view of how blue light may influence puberty in both male and female rats.”

While the findings suggest that blue light exposure could potentially be a risk factor for earlier puberty onset, more research is needed. “I want to emphasise that this is a rat study and direct results cannot be interpreted for humans. However, we provide an experimental foundation to further investigate the health consequences of ever-increasing screen time in modern society,” said Dr Kılınç Uğurlu.

The researchers will next focus on assessing the impact of blue light exposure before puberty in adult rats. “We aim to expose both male and female rats to blue light before puberty and understand its long-term effects on reproductive organ damage and fertility,” said Dr Kılınç Uğurlu. “Ultimately, this research could lead to preventative measures and contribute to the ongoing discourse on how modern lifestyles affect physiological development and long-term health.”

Reference:

Aylin Kılınç Uğurlu, Aysun Bideci,  Ayşe Mürşide Demirel, Gülnur Take Kaplanoğlu, Duygu Dayanır, Özlem Gülbahar, Tuba Saadet Deveci Bulut, Esra Döğer Mahmut Orhun Çamurdan, Is blue light exposure a cause of precocious puberty in male rats?, https://doi.org/10.3389/fendo.2023.1190445.

1 year 8 months ago

Pediatrics and Neonatology,Pediatrics and Neonatology News,Top Medical News,Latest Medical News

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

Brolucizumab treatment associated with visual acuity improvement for neovascular age-related macular degeneration

Brolucizumab is a low molecular weight humanized antibody
fragment as a vascular endothelial growth factor (VEGF) inhibitor. Registered
Phase III clinical trials HAWK and HARRIER showed brolucizumab was associated
with gains in visual acuity (VA) that were statistically noninferior to
aflibercept for treatment-naïve patients with active choroidal

Brolucizumab is a low molecular weight humanized antibody
fragment as a vascular endothelial growth factor (VEGF) inhibitor. Registered
Phase III clinical trials HAWK and HARRIER showed brolucizumab was associated
with gains in visual acuity (VA) that were statistically noninferior to
aflibercept for treatment-naïve patients with active choroidal
neovascularization secondary to neovascular age related macular degeneration
(nvAMD). Brolucizumab received FDA approval on October 8th, 2019 for the
treatment of nvAMD in the US. The recommended dosage regimen is 6 mg/0.05 mL
via intravitreal injection (IVI) monthly for the first 3 doses, then once every
8–12 weeks.

With growing uncertainty concerning the safety and efficacy
of brolucizumab relative to other anti-VEGF agents, authors Nicholas J Saba and
Scott D Walter set out to retrospectively analyze practice’s initial
post-marketing experience with brolucizumab during the first 8 months following
FDA approval of the drug on October 7, 2019. Unlike the clinical trial
population which enrolled only treatment-naïve eyes with nvAMD, this study
population was mostly comprised of eyes switched from another anti VEGF therapy
(563/626 eyes, 89.9%). Typically, these patients were switched to brolucizumab
for persistent fluid, or with the hope of achieving a longer treatment
interval. As such, this was a nonrandom and highly selected population of NVAMD
patients. However, authors felt that this population was probably more
representative of the nvAMD patients currently being treated with brolucizumab
in the United States. Study research questions included whether switching to
brolucizumab was associated with changes in VA, improvement in anatomic
outcomes, or increases in treatment interval; and whether the observed
incidence of adverse events following IVI of brolucizumab was similar to the
SRC analysis of the HAWK and HARRIER trials.

Study evaluated the visual and anatomic efficacy of
brolucizumab, examined changes in treatment intervals after switching to
brolucizumab, and estimated the incidence of drug-related adverse events in the
real world. This was a retrospective consecutive case series of 626 eyes (543
patients) with nvAMD treated with 1438 brolucizumab injections at a single
retina practice between 10/1/2019 and 5/15/2020. Changes in visual acuity (VA);
anatomic outcomes assessed by optical coherence tomography (OCT) including
central subfield thickness (CST), macular volume (MV), presence of intraretinal
fluid (IRF), subretinal fluid (SRF), and serous pigment epithelial detachment
(sPED) on foveal line scans; treatment intervals before and after receiving
brolucizumab; and the incidence of brolucizumab-related adverse events.

The majority of eyes (N = 531, 89.7%) had received prior
anti-VEGF therapy with aflibercept, ranibizumab, and/or bevacizumab. VA
improved in treatment-naïve eyes (+3.7 letters, p = 0.04), and was maintained
in previously treated eyes. There were significant improvements in all anatomic
outcomes in both groups (p < 0.001). Study observed a 4.8% incidence of
intraocular inflammation (IOI) and a 0.6% incidence of retinal vasculitis. The
average treatment interval increased from 6.3 to 6.8 weeks (p = 0.001).

“Our real-world experience with brolucizumab largely
confirmed the key findings of the HAWK and HARRIER trials. Treatment naïve
patients showed significant improvements in vision and anatomy after initiating
treatment with brolucizumab. Previously treated eyes maintained VA after
switching to brolucizumab, supporting the claim of noninferiority to other
anti-VEGF agents. Our analysis found that brolucizumab was highly effective in
reducing fluid within all retinal compartments, even in previously treated
nvAMD eyes. We found that patients may achieve extended dosing intervals
shortly after switching to brolucizumab, especially those with prior treatment
intervals.”

Keywords: Beovu, brolucizumab, anti-VEGF, intraocular
inflammation, retinal vasculitis

Source: Nicholas J Saba, Scott D Walter; Clinical
Ophthalmology 2023:17 2791–2802

1 year 8 months ago

Ophthalmology,Ophthalmology News,Top Medical News

STAT

STAT+: Pharmalittle: End of biotech’s stock market malaise may be near; cancer drug shortages hit rural clinics hard

Good morning! This is Jonathan Wosen, West Coast biotech and life sciences reporter, writing to you from sunny San Diego — though the sun won’t be up for another hour or so . I’m filling in for Ed Silverman while he’s away from the Pharmalot campus. And while I may not be a coffee drinker, never fear, as always we’ve got an interesting lineup of news to help kick-start your week. …

This was supposed to be the year the biotech industry recovered from its ongoing slump, but that simply hasn’t happened, STAT tells us. The industry remains locked in a slowdown that began in late 2021, with investors saying that despite the profit prospects of weight-loss drugs made by Big Pharma, they’ve soured on the sector at large. That could change if the Federal Reserve lowers interest rates and if more biotechs successfully go public in 2024, according to cautiously optimistic observers.

Japan’s health ministry has approved Leqembi, an Alzheimer’s drug developed by Eisai and Biogen, Reuters explains. Eisai, a Japanese pharma firm, spearheaded work on the drug, which clinical trials found modestly slowed the progression of Alzheimer’s. Eisai must now win reimbursement approval from the country’s national health system, after which the company has said it will begin marketing the drug in Japan within two months.

Continue to STAT+ to read the full story…

1 year 8 months ago

Pharma, Pharmalot, pharmalittle, STAT+

PAHO/WHO | Pan American Health Organization

PAHO convenes ministers of Health of the Americas to discuss Health priorities for the Region 

PAHO convenes ministers of Health of the Americas to discuss Health priorities for the Region 

Cristina Mitchell

25 Sep 2023

PAHO convenes ministers of Health of the Americas to discuss Health priorities for the Region 

Cristina Mitchell

25 Sep 2023

1 year 8 months ago

Jamaica Observer

NAJ satisfied with health ministry's dengue fight, Opposition throws in support

ROSE HALL, St James — The newly installed president of the Nurses Association of Jamaica (NAJ) Dawn-Marie Richards said the association is satisfied with the measures being implemented by the Ministry of Health and Wellness to address the ongoing dengue virus outbreak.

Local health authorities are or will be undertaking fogging, searching, identifying and destroying mosquito-breeding sites and undertaking public education among other things.

"Yes, I am. Those are the measures that we usually implement. Using technology, you know, we improve on what we implement but basically, the management is the same," stated Richards.

Richards was fielding questions from journalists following the association's 54th Island Conference on Saturday. This was held at the Hilton Rose Hall Resort and Spa in St James.

Richards, who is a senior public health nurse attached to the St Mary Health Department within the North East Regional Health Authority, was selected on Friday and installed as the 36th president of the 78-year-old organisation on Saturday night. She takes over from Patsy Edwards Henry.

While the country was on a dengue watch for more than a week, the ministry officially declared an outbreak on Saturday.

Richards argued that dengue is endemic to Jamaica and an outbreak can be expected at least every four years.

"So, we have put systems in place — the wheels have been in motion to manage dengue as is necessary," stated the president.

"We have been able to manage dengue over the years. So, we just implore persons to do what they have to do as we do what we have to do," added Richards.

Richards said the association has not had any expressions of concern at this time from her membership but will be on the lookout for any.

However, she said there were safety concerns for all.

"There are concerns that persons maintain their safety. The safety of our nurses is paramount, the safety of our facility is also paramount and we know that the Ministry of Health, at this time, is addressing those concerns," stated Richards.

In a press release on Sunday, the Opposition spokesperson on health, Dr Morais Guy called on citizens to pay close attention to the messages, bulletins and updates from the Ministry of Health, its departments and agencies.

Besides, Dr Guy appealed to citizens to immediately begin cleaning and clearing their yards and communities of debris, in particular, old cans and tyres which collect water and become a prime breeding area for the Aedes aegypti mosquito, the carrier of the dengue fever virus.

Symptoms associated with the virus include sudden fever, headache, pain behind the eye, nausea, vomiting, body aches and a rash.

The country last experienced a dengue outbreak in 2019.

1 year 8 months ago

News Archives - Healthy Caribbean Coalition

Octagonal Warning Labels Help Consumers Act on Facts

The Caribbean is facing a health crisis that is largely being driven by unhealthy diets filled with ultra-processed food products (UPPs) that sometimes masquerade as healthy options.

Although some industry players propose alternative labelling options, with our people’s health on the line, we need the label that is backed by sound, scientific research; and the Octagonal Warning Label (OWL) is 9 TIMES more effective at helping us quickly, correctly and easily identify products that are high in sugars, sodium and fats than other labeling system.

THE OCTAGONAL WARNING LABEL IS AT THE CENTRE OF A WIDER STRATEGY!

The Octagonal Warning Label enables other healthy food policies because it clearly and effectively identifies products that are high in sugars, sodium and fats and, therefore, harmful to health of our families and children.

This means it makes it easier to design, implement and enforce healthy policies like:

  • Regulating the sale and marketing of these unhealthy food products in and around schools, and school settings like youth sporting events
  • Regulating the marketing of these foods to children
  • Taxing unhealthy food products and subsidising healthy foods

So, the Octagonal Warning Label is a crucial launchpad for these policies that can protect our children and families, and also make it easier and more affordable for citizens to make healthy food choices.

THIS VOTE AND THESE POLICIES ARE MORE IMPORTANT THAN EVER!

Modern diets lack fresh, minimally processed food and are inundated with ultra- processed food products high in sugar, fats and salt which lead to our region’s biggest killers: obesity, diabetes, hypertension, high blood pressure and even some cancers.

With these ultra-processed food products being made easily accessible, attractively marketed, cheap and convenient, it’s more important than ever to have clear facts about the food we buy and consume.

That clarity can go a long way toward helping us make healthier food choices and protect our families and children from the harmful results of unhealthy options.

It is a step toward rebuilding the health of our population one family, one meal, one choice at a time!

PEOPLE LIVING WITH DIET-RELATED DISEASES NEED CLEAR NUTRITIONAL FACTS!

Everyone should to be able to correctly and easily identify foods high in sugar, sodium and fats.

But, for people living with living with diabetes, hypertension, high blood pressure, obesity and even some cancers, clarity and honesty can actually help to control their conditions, and ultimately save their lives by helping them make better, healthier choices in the long-term!

IT’S JUST EASIER TO MAKE HEALTHY CHOICES WHEN THE FACTS ARE CLEAR!

Appealing and persuasive package designs, clever marketing and misleading claims on packaging, and confusing nutrition labels can often lead to unhealthy food products being mistaken as “good for us”. Consumers need help to combat these tactics.

This is why we need a label that provides clear facts that let us quickly, correctly and easily identify unhealthy food products.

CAMPAIGN AT A GLANCE

Launch Date: Monday | 25 SEPTEMBER, 2023

Locale: Regional/Caribbean

Type: Social Media Campaign

Purpose: To advocate and build support for the current final draft regional standard for labelling pre-packaged foods, which includes the octagonal front-of-package warning labelling system.

In October 2023, CARICOM countries voted on whether to approve the Octagonal Warning Labels or not. Thanks to everyone who signed the petition in support of the Octagonal Warning Label!

1470

People Signed (including Caribbean Academics, Researchers and Health Practitioners)

RELATED RESOURCES

The post Octagonal Warning Labels Help Consumers Act on Facts appeared first on Healthy Caribbean Coalition.

1 year 8 months ago

Campaigns, Front-of-Package Nutrition Warning Labels, News, Slider, Timeline, STT1

Health News Today on Fox News

Jellyfish are not the 'simple creatures' once thought: New study may change an understanding of our own brains

Jellyfish could be much smarter than scientists previously thought, asserts a new study published in the journal Current Biology.

Jellyfish could be much smarter than scientists previously thought, asserts a new study published in the journal Current Biology.

Poisonous Caribbean box jellyfish can learn at a far more complex level than ever imagined, despite only having 1,000 nerve cells and no centralized brain, according to new research from the University of Copenhagen.

Scientists say their findings change the fundamental understanding of the brain — and could reveal more about human cognitive functions and the process of dementia.

BOOST BRAIN HEALTH AND SLOW MENTAL AGING WITH 10 INTRIGUING TIPS FROM LONGEVITY EXPERTS 

Jellyfish have been around for over 500 million years — yet until now, they've been thought of as simple creatures with very limited learning abilities.

The prevailing scientific opinion is that more advanced nervous systems equate with elevated learning potential in animals.

Jellyfish and their relatives, collectively known as cnidarians, are considered to be the earliest living animals to develop nervous systems.

Neurobiologist and professor Anders Garm has been researching box jellyfish — a group commonly known for being among the world's most poisonous creatures — for more than a decade, the study noted.

WASHINGTON FISHERMAN CATCHES MASSIVE RECORD-BREAKING MAHI MAHI: 'PRAYED FOR THAT'

The fingernail-sized species lives in Caribbean mangrove swamps; there, they use their impressive visual system, including 24 eyes, to hunt for tiny copepods (small crustaceans) among the roots, as SWNS reported on the background of the research.

Garm of the University of Copenhagen in Denmark said, "It was once presumed that jellyfish can only manage the simplest forms of learning, including habituation — the ability to get used to a certain stimulation, such as a constant sound or constant touch," according to SWNS.

"Now, we see that jellyfish have a much more refined ability to learn — and that they can actually learn from their mistakes… [and] modify their behavior."

One of the most advanced attributes of a nervous system, he said, is the ability to change behavior as a result of experience — to remember and learn.

As the tiny box jellyfish approach the mangrove roots, they turn and swim away. If they veer off too soon, they won’t have enough time to catch any copepods. Yet if they turn away too late, they risk bumping into the root and damaging their gelatinous bodies, the study noted.

Assessing distances is crucial for them, Garm said — and the research team discovered that contrast is the key.

"Our experiments show that contrast — how dark the root is in relation to the water — is used by the jellyfish to assess distances to roots, which allows them to swim away at just the right moment," he said, as SWNS noted.

"Even more interesting is that the relationship between distance and contrast changes on a daily basis due to rainwater, algae and wave action," the professor continued. "We can see that as each new day of hunting begins, box jellyfish learn from the current contrasts by combining visual impressions and sensations during evasive maneuvers that fail."

FISHERMAN IN ALASKA REELS IN CATCH THAT'S BRIGHT BLUE ON THE INSIDE: 'PRETTY CRAZY'

"So, despite having a mere 1,000 nerve cells — our brains have roughly 100 billion — they can connect temporal convergences of various impressions and learn a connection, or what we call associative learning," Garm said. "And they actually learn about as quickly as advanced animals like fruit flies and mice."

The findings contradict previous scientific perceptions of what animals with simple nervous systems are capable of, the study indicated.

"For fundamental neuroscience, this is pretty big news," Garm said. "It provides a new perspective on what can be done with a simple nervous system."

"This suggests that advanced learning may have been one of the most important evolutionary benefits of the nervous system from the very beginning."

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The research also indicated where the learning is happening inside the box jellyfish. The team said the discovery has given them unique opportunities to study the precise changes that occur in a nerve cell when it's involved in advanced learning.

Said Garm, "We hope that this can become a supermodel system for looking at cellular processes in the advanced learning of all sorts of animals," as SWNS noted.

"We are now in the process of trying to pinpoint exactly which cells are involved in learning and memory formation," he said. 

"Upon doing so, we will be able to go in and look at what structural and physiological changes occur in the cells as learning takes place."

If the team is able to pinpoint the exact mechanisms involved in jellyfish's learning functions, the next step will be to find out whether those apply only to them or if they can be found in all animals, Garm noted.

"Understanding something as enigmatic and immensely complex as the brain is in itself an absolutely amazing thing," he said. "But there are unimaginably many useful possibilities."

"One major problem in the future will undoubtedly be various forms of dementia," he added, as SWNS also reported. 

"I don’t claim that we are finding the cure for dementia — but if we can gain a better understanding of what memory is, which is a central problem in dementia, we may be able to lay a building block to better understand the disease and perhaps counteract it."

For more Health articles, visit www.foxnews.com/health

1 year 9 months ago

wild-nature, lifestyle, science, Water, medical-research, mental-health, alzheimers, Health

PAHO/WHO | Pan American Health Organization

PAHO Director Urges Caribbean Health Ministers to Utilize Collective Action

PAHO Director Urges Caribbean Health Ministers to Utilize Collective Action

Cristina Mitchell

24 Sep 2023

PAHO Director Urges Caribbean Health Ministers to Utilize Collective Action

Cristina Mitchell

24 Sep 2023

1 year 9 months ago

Medical News, Health News Latest, Medical News Today - Medical Dialogues |

Type 1 diabetes linked to early onset of puberty among boys and girls

Puberty in both girls and boys with type 1 diabetes has shifted forward over the last two decades, according to research presented at the 61st Annual European Society for Paediatric Endocrinology Meeting in The Hague. Additionally longer duration of diabetes, bigger waistlines, and lower blood sugar levels were associated with even earlier puberty onset.

The findings of this large-scale study highlight a close relationship between type 1 diabetes and puberty onset and the utmost importance of managing diabetes and weight appropriately during puberty.

Type 1 diabetes is the most common form of diabetes in children. Puberty brings about hormonal changes that can impact metabolic control in diabetes, for instance the body can become more resistant to insulin, increasing blood sugar levels. In recent years, many studies have reported earlier puberty onset across the world, particularly in healthy girls. However, diabetes is known to be associated with a delay of pubertal onset in children.

In this study, researchers from Germany analysed data on the onset of puberty and pubic hair development of 65,518 children aged 6-18 years, all diagnosed with type 1 diabetes between 2000 and 2021, from the German DPV registry. They found that over two decades both girls and boys are going through puberty at about six months earlier than before. This result was more evident in children who had diabetes longer, were overweight, or had lower blood sugar levels.

“While the findings for girls align with previous research, our study is groundbreaking in revealing a similar trend in boys with type 1 diabetes for the first time,” said lead researcher Dr Felix Reschke from the Children’s Hospital Auf Der Bult in Hanover. “As a result, we now anticipate that the average onset of puberty in boys with diabetes will occur just before the age of 12 (11.98 years).”

He adds: “Our study demonstrates that children with diabetes are also experiencing this trend towards an earlier puberty, which is already known in healthy girls, but not evident in boys yet. It's also important to note that previous research indicated that type 1 diabetes may lead to delayed pubertal onset, thus our study provides new insights into the complex relationship between type 1 diabetes and puberty onset.”

Many factors that alter puberty in children, such as body weight, disease and genetics, have been associated with early puberty. However, early puberty often does not have an obvious cause. “Our research not only sheds light on the evolving landscape of puberty timing in children with type 1 diabetes but also underscores the intricate interplay between metabolic factors, hormones, and environmental influences,” said Dr Reschke. “Further investigations are warranted to explore these dynamics comprehensively and inform targeted interventions for this vulnerable population.”

The researchers will now compare this trend of an early onset of puberty with children without chronic diseases and delve deeper into understanding the underlying causes. “It is crucial for both society and pediatricians to recognise this trend, and if necessary, we may need to reevaluate and adjust our clinical approaches to examining premature puberty accordingly,” said Dr Reschke.

1 year 9 months ago

Diabetes and Endocrinology,Pediatrics and Neonatology,Diabetes and Endocrinology News,Pediatrics and Neonatology News,Top Medical News,Latest Medical News

Jamaica Observer

Five points about a myomectomy

UTERINE fibroids continue to tremendously impact the quality of lives of Jamaican women.

Uterine fibroids are non-cancerous growths of the muscle of the uterus. The symptoms of uterine fibroids vary widely and may include: severe anemia (low iron levels causing shortness of breath, weakness and uncontrolled heart racing), painful, prolonged and heavy periods, an increase in abdominal size (due to the growth of the fibroids), constipation, shooting pains down the leg and urinary frequency.

One of the more frequent treatment options of fibroids is a myomectomy, which includes the surgical removal of fibroids with the preservation of the woman's uterus allowing her to conceive in the future.

Here are five points about a myomectomy women should be made aware of before proceeding with surgery :

1. Every myomectomy is different

Fibroids can vary in location, number and size. As a result, every patient's surgical approach is individualised.

Some patients may require a traditional (open) myomectomy, some may require a laparoscopic (keyhole surgery) myomectomy or some may require vaginal myomectomy (fibroids which have prolapsed through the cervix and into the vagina are surgically removed via the vagina).

These patient and uterine variations can result in various surgical times and potential specific complications depending on the scenario of the patient. No myomectomy is the same.

2. Possibility of a Caesarean section in the future

Most myomectomies involve removal of several fibroids throughout the entire level of the uterus. If fibroids are located and removed from the uterine cavity (where the baby develops) and this cavity is opened (and repaired), these patients are required to have a Caesarean section in the future.

The reason for this is that these patients when they become pregnant in the future are at risk of uterine rupture — a condition where the uterus opens under the pressure of labour and can lead to the baby dying and also the mother bleeding internally.

This is a catastrophic event and should be best avoided with planned Caesarean sections for women who had previous myomectomies.

3. The uterus can take up

Most women after myomectomy may experience a significant relief in symptoms the first month following surgery. However, some women may not.

The uterus can take up to four months to fully heal and restructure. As a result, during this time, even if all fibroids were removed, patients may still have symptoms.

4. Fibroids can return

The exact cause of fibroids are unknown. There have been links to genetics, family history and diet.

Patients must be informed that even though a myomectomy was successfully done, fibroids can return in the future. The time interval can be sporadic, and patients should still be encouraged to have yearly visits with their gynaecologists to identify any signs or symptoms of fibroid return.

5. Complications with surgery

All surgeries are associated with risks and benefits. The main benefit of a myomectomy is to improve a woman's quality of life.

Patients must be made aware of all complications prior to surgery and informed written consent should be obtained prior to surgery also. Complications specific to myomectomy, although rare, include:

Infection

Bleeding

Risk of blood transfusion

Risk of emergency hysterectomy (removal of uterus — live-saving event)

Risk of blood clot formation (pulmonary embolism, deep vein thrombosis)

Injury to other organs — bowel, bladder

Risk of bowel obstruction

Death

Further, ensure your doctor details you properly on a myomectomy procedure.

Dr Daryl Daley is a cosmetic gynaecologist and obstetrician. His office is located at 3D Gynaecology Ltd. at 23 Tangerine Place, Kingston 10 and the office number is 876-929-5038/9. He can be contacted at ddaley@3dgynae.com.

1 year 9 months ago

Jamaica Observer

Consumer wearable devices and heart health — Part 2

In our last article we introduced consumer wearable devices (CWDs) and its use in monitoring heart rate and rhythm. This week we will focus on some other physiological markers that these devices can evaluate.

1. Steps

In our last article we introduced consumer wearable devices (CWDs) and its use in monitoring heart rate and rhythm. This week we will focus on some other physiological markers that these devices can evaluate.

1. Steps

It has become part of popular culture that for good health one should walk 10,000 steps per day. It is interesting to note, however, that this recommendation has an anecdotal origin. It originated in 1960s Japan where the Yamasa corporation produced a pedometer (a device that counts steps walked) with the nickname manpo-kei (literally translated 10,000 steps meter). This nickname was widely adopted by Japanese walking clubs of the time. Subsequent studies in Japan found that for an average Japanese male this amount of walking led to the burning of 300kcal/day and the setting of this goal for a healthy lifestyle by the Japanese Health Ministry. Currently, when thinking about exercise prescription, most Western organisations recommend a duration of aerobic activity of 150 minutes per week of moderate exercise or 75 minutes per week of intense exercise as opposed to counting steps. It is, however, clear that there are health outcomes that are associated with the number of steps taken daily. Higher step counts are associated with a lower risk of death and a lower risk of cardiovascular disease. A recent meta-analysis combining 15 studies from several countries found that in the population above the age of 60, walking more than 6000-8000 steps was associated with a lower risk of death, whereas for those below the age of 60 years, 8000-10000 steps were required.

There is some data that suggests that simply wearing a CWD that counts steps increases the number of steps that are taken and thus there is the potential for lowering the risk of death and developing cardiac disease in those who wear these devices. CWDs measure step counts by using accelerometers and gyroscopes which respond to motion of the body part to which the device is attached. The accuracy of CWDs for calculating steps can be quite variable, with some devices consistently overestimating or underestimating steps taken when compared to the gold standard using video recording to count steps walked. The accuracy has been found to vary with the manufacturer, the model, the speed of walking, and body position of the CWD. It is important to say, however, that given the relatively wide ranges for which benefit has been shown (6000-8000 or 8000-10000) a device that is extremely accurate may not be required. From a health perspective sufficient evidence exists to encourage those who do not get enough steps in on a day-to-day basis to either increase their step count or follow the duration guidelines for weekly exercise.

2. Oxygen saturation

Several CWDs can measure the blood oxygen saturation. This is done by measuring the absorption of a light source by haemoglobin. There is variation in the amount of light absorbed in proportion to the amount of oxygen that is bound to the haemoglobin molecule and thus the percentage saturation (a measure of the amount of oxygen in the blood) can be calculated. A value of 95 per cent or above is considered to be normal. One important exception is during exercise when studies have found that male competitive athletes can have low saturation levels (less than 93 per cent or 91 per cent depending on the study) in more than 70 per cent of those studied. This feature of CWDs was of much importance during the recent COVID-19 epidemic when low oxygen saturations were used to identify patients who needed hospitalisation or intensification of medical care. Several CWDs have been found to have accuracy similar to medical-grade oximetry devices; however, there has been limited testing comparing CWDs to the gold standard measurement of the blood gas levels in arterial blood.

Given the fact that the measurement of oxygen saturation depends on light penetration of skin, there are concerns about the accuracy of these measurements in dark-skinned individuals. It has been shown that melanin, which is present in those with darker skin, can absorb the projected light leading to inaccuracies in the calculated oxygen saturation. The clinical impact of this has been seen during the COVID-19 epidemic. A retrospective study looking at over 25,000 patients found that medical-grade oximetry devices were more likely to overestimate the amount of oxygen in the blood in black and Hispanic patients when compared to white patients. This overestimation led to a reduced ability to identify black patients who needed more aggressive care when compared to white individuals and translated into 10 per cent less appropriate therapy in these dark-skinned individuals. Given these limitations of measurement of oxygen saturation in black and Hispanic populations, studies are being conducted to improve the accuracy of these devices. Over-reliance should not be placed on a normal oxygen saturation if symptoms suggest significant respiratory issues.

3. Sleep

Sleep is increasingly recognised as an important component of a healthy lifestyle, and it is recommended that most adults get at least 7 hours of sleep per night although this can vary substantially in a particular individual. The scientific evaluation of sleep duration and sleep quality is well established and can be performed using polysomnography. This testing involves sleeping in a medical facility and recording various physiological parameters, including the electrical activity of the brain, eye movements, limb movements, heart rate, and respiration. CWDs do offer the ability to assess some aspects of sleep at home. In evaluating sleep, CWDs assess motion with accelerometers, measuring whether the limbs (most commonly the arms) are moving. In addition to limb movement, different devices will combine additional physiological data to improve discrimination of the duration and the stage of sleep such as heart rate and respiratory rate.

Given the fact that consumer wearable devices are primarily looking at limb movements, there is the tendency for the devices to underestimate sleep in people who have movement disorders during sleep and overestimate sleep duration in those who have limited movements when lying in bed awake. These devices have also been shown to be poor at detecting waking episodes during the middle of the night. When studied against the gold standard of polysomnography, CWDs do fairly well in detecting sleep duration, but they perform less well in classifying sleep stages, tending to overestimate light sleep and deep sleep and underestimate sleep with rapid eye movement.

Sleep apnoea is increasingly recognised as a common condition and serves as a risk factor for some medical conditions, including hypertension and cardiac arrhythmias. Given the ability to recognise falls in oxygen saturation, respirations, and heart rate, CWDs can indicate abnormalities that may suggest a diagnosis of sleep apnoea. There is also the opportunity to use cellphone microphone recording to detect snoring; however, further research needs to be done to define the usefulness of CWDs in this setting. It is important to remember that sleep duration is the primary goal, in terms of sleep quality for the general population. The use of CWDs can be useful in recording and following this over time. People who have markers of poor sleep duration or other abnormalities noted on CWDs can speak with their physicians about a formal medical-grade sleep study.

As we pointed out in the first article, the use of consumer wearable devices is increasing and bringing health data to our fingertips in easily accessible forms. It is important to be aware of some of the limitations of this data, but there is significant potential for individual monitoring of previously inaccessible physiological findings and possible improvement in health outcomes by leveraging this data.

Dr Ernest Madu, MD, FACC and Dr Paul Edwards, MD, FACC are consultant cardiologists for the Heart Institute of the Caribbean (HIC) and HIC Heart Hospital. HIC is the regional centre of excellence for cardiovascular care in the English-speaking Caribbean and has pioneered a transformation in the way cardiovascular care is delivered in the region. HIC Heart Hospital is registered by the Ministry of Health and Wellness and is the only heart hospital in Jamaica. Send correspondence to info@caribbeanheart.com or call 876-906-2107.

1 year 9 months ago

Jamaica Observer

Raising awareness on lung health

WORLD Lung Day 2023, celebrated globally on September 25, presents an opportunity to shed light on the critical importance of lung health and raise awareness about the challenges and solutions related to lung diseases.

This year, individuals, organisations, and governments worldwide come together under the theme 'Access to prevention and treatment for all. Leave no one behind' to address the pressing issues facing lung health.

Lung diseases, including chronic obstructive pulmonary disease (COPD), asthma, lung cancer, pulmonary fibrosis, pulmonary hypertension, interstitial lung disease (ILD) and respiratory infections, remain a combined global public health challenge. According to the World Health Organization (WHO), over 4 million people die prematurely from respiratory diseases each year, and millions more suffer from chronic lung conditions that impact their quality of life.

World Lung Day is a call to action to:

1. Raise awareness: It serves as a platform to educate the public about the importance of lung health, common lung diseases, and the risk factors associated with them.

2. Advocate for change: World Lung Day encourages governments, health-care providers, and stakeholders to prioritise lung health policies, research, and funding.

3. Support patients: It highlights the need for accessible, affordable, and equitable health-care services for individuals living with lung diseases.

4. Promote clean air: Addressing air pollution, tobacco control, and other environmental factors that affect lung health is a central focus of World Lung Day.

Marie Ricketts-Scott, founding director of Jamaica Lung Support, emphasized the significance of this day, stating, "World Lung Day is a global call to action for lung health. We aim to raise awareness about lung diseases and advocate for policies that can positively impact lung health in Jamaica. It is crucial for individuals to understand that many lung diseases are incurable, and early detection can make a significant difference."

In the spirit of 'Access to prevention and treatment for all. Leave no one behind' Jamaica Lung Support is proud to announce the launch of its groundbreaking Pay It Forward Medication Initiative. This initiative will provide subsidised medication and support to eligible individuals, ensuring they can manage their conditions effectively.

Everyone is encouraged to participate in World Lung Day 2023 by spreading awareness on social media using the hashtag #WorldLungDay and taking steps to protect their own lung health and that of their communities.

Let us provide access to prevention and treatment for all; leave no one behind on World Lung Day 2023. The ability to breathe is the greatest gift because when you cannot breathe, nothing else matters.

1 year 9 months ago

Health News Today on Fox News

Jamaica declares Dengue fever outbreak with hundreds of confirmed and suspected cases

Health officials in Jamaica have declared an outbreak of the dengue fever Saturday with at least 565 suspected, presumed and confirmed cases in the Caribbean nation. 

Health officials in Jamaica have declared an outbreak of the dengue fever Saturday with at least 565 suspected, presumed and confirmed cases in the Caribbean nation. 

Jamaica’s Ministry of Health and Wellness says the outbreak comes as its National Surveillance Unit "advised that Jamaica has surpassed the dengue epidemic threshold for July and August and is on a trajectory to do the same for the month of September." 

"The dominant strain is Dengue Type 2, which last predominated in 2010," it said. "There are no dengue-related deaths classified at this time, however, six deaths are being investigated." 

Health officials say there currently are at least 78 confirmed cases of the mosquito-borne disease in Jamaica. 

MOSQUITOS, FEARED FOR SPREADING DENGUE, NOW BEING BRED TO FIGHT THE DISEASE 

"Meanwhile, approximately 500 temporary vector control workers have been engaged and deployed across the island to high-risk communities along with 213 permanent workers," the Ministry of Health and Wellness also said. 

The Centers for Disease Control and Prevention (CDC) says dengue viruses are "spread to people through the bite of an infected Aedes species mosquito." 

About one in four people infected will get sick, with mild symptoms including nausea, vomiting, rash, aches and pains, according to the CDC.

Recovery takes about a week. 

DENGUE FEVER CASES COULD REACH NEAR-RECORD HIGHS THIS YEAR 

Around 1 in 20 people infected will develop severe dengue, which the CDC says "can result in shock, internal bleeding, and even death." 

"The Ministry and Regional Health Authorities have made the necessary preparations for a possible outbreak," said Christopher Tufton, the Minister of Health in Jamaica. 

The Ministry is warning the public in Jamaica that the Aedes aegypti mosquito "breeds in any containerized environment" that can hold water, such as drums, tires, buckets and animal feeding containers. 

"Persons are urged to play their part in ensuring that the cases are minimized by monitoring water storage containers for mosquito breeding, keeping surroundings free of debris, destroying or treating potential mosquito breeding sites, wearing protective clothing, using mosquito repellent and, as much as possible, staying indoors at dusk with windows and doors closed," it also said. 

1 year 9 months ago

infectious-disease, World, caribbean-region, Health

Health – Dominican Today

Authorities do not know when dengue fever will decrease

Santo Domingo.- The Vice Minister of Collective Health, Eladio Perez, has no fixed date for the dengue epidemic to decline. He thinks that the country is now facing a plateau. If there is no drop in cases, the disease affecting the Dominican Republic could continue its impact until the end of the year, according to infectologists.

Santo Domingo.- The Vice Minister of Collective Health, Eladio Perez, has no fixed date for the dengue epidemic to decline. He thinks that the country is now facing a plateau. If there is no drop in cases, the disease affecting the Dominican Republic could continue its impact until the end of the year, according to infectologists.

The official has the perception that in the coming weeks if the current behavior continues, the disease could go down. He believes that there is a slight drop in patient admissions.

You can read Ariel Henry to the UN: “The Republic of Haiti is not at war with anyone.”

There will always be cases because the disease is endemic. The cessation of the high incidence will depend on the pattern; if it continues now, there will be fewer cases in the coming weeks, said the official who manages the country’s collective health.

“We need a little more time, if the disease continues to go down the country would be in improvement,” said the epidemiologist. In his opinion, the final phase of the disease cannot be determined by the behavior of a week.

Clinics to attend
The director of the National Health Service (SNS) hospital network, Yocasta Lara, asked the directors of the National Association of Private Clinics (Andeclip) to provide more beds.

In the public sector, the clinics refer patients to them, most of whom are under 19 years of age.

Almost all the cases are being attended by two large public hospitals and one of a patronage hospital.

The Hugo Mendoza pediatric hospital leads in admissions, followed by the Robert Reid Cabral and the General Hospital of the Plaza de la Salud in third place.

The Santiago Clinic, Unión Médica, and the Arturo Grullón hold the fourth place in the same city. The Jaime Mota de Barahona also has cases of children and adults.

Behavior
The end of this epidemic outbreak, as the authorities have called it, will depend on the behavior of the vector through which the disease is transmitted, the Aedes aegypti mosquito.

The hospitals
Dr. Yocasta Lara, director of the SNS hospital network, reported yesterday on the number of patients admitted with dengue fever.

She also reported that the Robert Reid Cabral hospital had 64 children admitted. Three children remain in intensive care at this center.

The Marcelino Vélez Santana hospital has 21 admissions, the Juan Pablo Pina, 10, the Arturo Grullón, 13, and 12 at the San Lorenzo de Los Mina. Lara indicated that the Jaime Mota hospital in Barahona has 26 patients admitted: Jacinto Mañón, seven; El Almirante, six; Boca Chica, 19; and Félix María Goico, three admissions.

Plaza de la Salud
At the Plaza de la Salud General Hospital (HGPS), where many patients, mostly children, have been treated, 17 patients were admitted yesterday and are still waiting.

1 year 9 months ago

Health, Local

Health – Dominican Today

Cases of dengue fever increase in children population in Santiago

Santiago, DR.- The number of patients affected by dengue fever has increased among children in the last few days here, while among adults, the cases are sporadic and isolated, according to reports from the three most important public hospitals in this province.

Santiago, DR.- The number of patients affected by dengue fever has increased among children in the last few days here, while among adults, the cases are sporadic and isolated, according to reports from the three most important public hospitals in this province.

Reports also indicate that private clinics continue to receive patients with symptoms of the disease transmitted by the Aedes aegypti mosquito.

The director of the children’s hospital, Dr. Arturo Grullon, Dr. Mirna Lopez, reported that this health center handles an average of 15 to 20 patients affected by dengue daily, experiencing a slight increase in emergency and outpatient consultations of febrile patients.

Dr. Mirna López, director of the children’s hospital, Dr. Arturo Grullón.

She said that of the total number of children admitted, only one is in intensive care, and his health remains stable. So far this year, two patients have died from the disease.

López explained that most of those affected by dengue come from different sectors of Santiago, such as Pueblo Nuevo, Cienfuegos, Jacagua, San José de Las Matas, as well as Montecristi and other towns of the Cibao region.

Meanwhile, in the hospitals José María Cabral y Báez and Presidente Estrella Ureña, the cases of dengue fever are sporadic. For example, at the Cabral y Baez hospital, there have been six cases of dengue in the last 15 days; 4 of them were admitted and subsequently sent home, according to the medical director, Manasés Peña.

Only two patients had been admitted to the Presidente Estrella Ureña Hospital recently.

President Estrella Ureña Hospital
On the other hand, the provincial authorities of Public Health informed that they continue the fumigation and cleaning up of garbage in various sectors of Santiago as a prevention against dengue fever and other diseases transmitted by vectors.

The cleaning activities, orientation, and education to combat dengue are conducted in schools, colleges, and neighborhood councils.

 

Dengue mosquito (External source)

Dengue mosquito (External source)

Corominas Clinic

At the Corominas clinic, one of the traditional private health centers in Santiago, there are currently 16 hospitalized patients, 2 of whom are in the intensive care unit, none of whom have died.

1 year 9 months ago

Health, Local

Pages